Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Eastgate Biotech Corp. Stock Analysis ETBI
United States N/A Nano Cap Eastgate Biotech Corp. engages in the development of novel formulations of natural compounds and pharmaceutical products. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-01-16. The firm utilizes nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all too often create dangerous side effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The company develops products in which active components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles), and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles). Its E-Drops NANO is used to combat urinary and vaginal tract infections. VCleanzz is an antibacterial wash for fruits and vegetables. Cleanezze is a natural hand sanitizer that will not dry or crack skin.
Read More Eastgate Biotech Corp (ETBI) Chart
Key Statistics of Eastgate Biotech Corp (ETBI)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
1500.00P/E Ratio (TTM)
-52 Week Range
Market Cap
720.00KAvg. Volume
3250.00Dividend Yield
-Financial Metrics & Statements of Eastgate Biotech Corp (ETBI)
FAQ's for Eastgate Biotech Corp (ETBI)
- According to Musaffa’s Shariah screening methodology, Eastgate Biotech Corp (ETBI) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Eastgate Biotech Corp using these criteria to determine its compliance status.
- Muslim investors may consider investing in Eastgate Biotech Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Eastgate Biotech Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Eastgate Biotech Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Eastgate Biotech Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.